This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Personal financial planning is vital for achieving long-term financial goals. Learn why it matters and how to get started effectively.
24,448 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
This guide breaks down what Greenlight Re (GLRE) investors should watch in the first-quarter 2026 results. Learn how ...
In this edition of the Morning Minute, Saylor is back to buying, signaling renewed confidence in Bitcoin. We break do...
The Nasdaq-100 reshuffle sparked by new AI and cloud players puts Charter and CoreWeave in the spotlight. This guide ...
Richtech Robotics stock fell sharply in June after the company disclosed restatements. This guide breaks down what ha...
Choosing between self-managing rentals and hiring a property manager is a pivotal decision for any landlord. This gui...
Turning $100,000 into $1 million by 2036 demands a high-growth plan and careful risk management. This article evaluat...
Investing often favors flashy stories, but some of the strongest returns come from straightforward, reliable business...
Private reverse mortgage products are outpacing HECMs, underscoring a broader push to revive the HECM for Purchase. I...
AI-driven data centers are reshaping the power grid, with Pennsylvania at the heart of the shift. New investments, wo...
Lulu's LVLU is shaping its 2026 earnings story through stronger direct channels, smarter pricing, and inventory disci...
Visa and OpenAI announced a collaboration to embed Visa's secure payments directly into ChatGPT, enabling users to pa...